LAMEA Laparoscopic Power Morcellators Market By Application (Hysterectomy, Myomectomy and Other Applications), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

The Latin America, Middle East and Africa Laparoscopic Power Morcellators Market is expected to witness market growth of 9.6% CAGR during the forecast period (2021-2027).

In recent years, non-invasive and minimally invasive surgeries have gained popularity. It is due to the lesser risk associated with these procedures. As there are smaller cuts in non-invasive surgeries and thus, there is minimum postoperative pain and ensure a speedy recovery. Due to all these advantages, there is high adoption of these procedures.

These days, surgeons also prefer to go for single-port laparoscopic and robotic myomectomies in order to remove larger fibroids. These larger fibroids are broken into small pieces called morcellation. These small pieces are removed through minor incisions with the help of laparoscopic power morcellators. As a result, it reduces the risks of blood loss and infection in non-invasive procedures as compared to open abdomen surgeries. All these advantages are cumulatively responsible to drive the demand for minimally invasive surgeries which, in turn, expected to drive the market for laparoscopic power morcellators during the forecast period.

The health care infrastructure is not very good in Sub-Saharan Africa. The adoption of technologically advanced healthcare devices including laparoscopic power morcellators is still low as compared to other developed countries. Thus, effective regulatory frameworks similar to international standards, are important to expand access to quality medical devices in these regions. It is expected that a streamlined regulatory process in African nations will attract innovators to bring advanced medical devices into the African market.

This, in turn, increases patient access to safe and advanced medical devices to improve the healthcare sector in this region. Many women in Africa are suffering from uterine fibroids, the majority of them are asymptomatic. There is no reliable method to differentiate uterine fibroid and cancerous tissue. Thus, the only possible way is to surgically remove the uterine fibroid by using a non-invasive surgical procedure involving laparoscopic power morcellators. Therefore, it is expected that the market of laparoscopic power morcellators will show significant growth in the coming years.

The Brazil market dominated the LAMEA Myomectomy Market by Country in 2020, thereby, achieving a market value of $778.4 Thousands by 2027. The Argentina market is expected to witness a CAGR of 9.8% during (2021 - 2027). Additionally, The UAE market is showcasing a CAGR of 8.3% during (2021 - 2027).

Based on Application, the market is segmented into Hysterectomy, Myomectomy and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Karl Storz SE & Co. KG, Cook Medical, Inc. (Cook Group), Olympus Corporation, Johnson and Johnson, Lina Medical, Nouvag AG, Rudolf Medical GmbH, OWA- Electronic GmbH & Co. KG, and Richard Wolf GmbH.

Scope of the Study

Market Segments covered in the Report:

By Application

• Hysterectomy
• Myomectomy
• Other Applications

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• Medtronic PLC
• Karl Storz SE & Co. KG
• Cook Medical, Inc. (Cook Group)
• Olympus Corporation
• Johnson and Johnson
• Lina Medical
• Nouvag AG
• Rudolf Medical GmbH
• OWA- Electronic GmbH & Co. KG
• Richard Wolf GmbH

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free